Article
Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) - 1 May 2011
Han Baohui, Gao Ge, Wu Wenting, Gao Zhiqiang, Zhao Xueying, Li Ling, Qiao Rong, Chen Hongyan, Wei Qingyi, Wu Jinchang, Lu Daru
Abstract excerpt
Platinum-based chemotherapy is the most common treatment for non-small cell lung cancer (NSCLC), and expression levels of drug metabolism and transport proteins are correlated with its efficacy and toxicity. In this study, we investigated the association of three putative functional polymorphisms of ABCC2 (C-24T, G1249A, and C3972T) with tumor response and occurrence of the grade 3 or 4 toxicity in 445 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
